Cytoreduction and HIPEC in the Netherlands: Nationwide long-term outcome following the dutch protocol

Annals of Surgical Oncology

Volumn 20, Issue 13, 2013, Pages 4224-4230

  Kuijpers, Anke M J ^a   Mirck, Boj ^a   Aalbers, Arend G J ^a   Nienhuijs, Simon W ^b   De Hingh, Ignace H J T ^b   Wiezer, Martinus J ^c   Van Ramshorst, Bert ^c   Ginkel, Robert J Van ^d   Havenga, Klaas ^d   Bremers, Andreas J ^e   Wilt, Johannes H W De ^e   Velde, Elisabeth A Te ^f   Verwaal, Vic J ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

^c ST ANTONIUS HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; MITOMYCIN; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOSIS; CHEMOTHERAPY; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; CYTOREDUCTIVE SURGERY; DATA BASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; OVERALL SURVIVAL; PATIENT SAFETY; PERITONEAL CARCINOMATOSIS; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE COMPLICATION; PROGRESSION FREE SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SIGNET RING CELL; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; PERITONEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84892374282     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3145-9     Document Type: Article

References (25)

1. Verwaal VJ, Van Ruth S, De Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737-43.
2. Integral Cancer Center the Netherlands (2011). The Netherlands Cancer Registration. http://www.cijfersoverkanker.nl. Accessed 12 Dec 2012.
3. Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99(5): 699-705.
4. Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JWW, De Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128(11):2717-25.
5. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358-63.
6. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63(2): 364-7.
7. Bloemendaal ALA, Verwaal VJ, Van Ruth S, Boot H, Zoetmulder FAN. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol. 2005;31(10):1145-51.
8. Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30(3):263-7.
9. Klaver YLB, Simkens LHJ, Lemmens VEPP, et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012;38(7):617-23.
10. Sugarbaker PH, Schellinx MET, Chang D, Koslowe P, Meyerfeldt M von. Peritoneal Carcinomatosis from Adenocarcinoma of the Colon. World J Surg. 1996;20(5):585-92.
11. Esquivel J, Sticca R, Sugarbaker P, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol. 2007;14(1):128-33.
12. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27(5):681-5.
13. Verwaal VJ, Ruth S Van, Witkamp A, Boot H, Slooten G Van, Zoetmulder FAN. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg. 2005;12(1):9-12.
14. Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116(24):5608-18.
15. Chua TC, Liauw J, Zhao J, Morris DL. Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis. Int J Clin Oncol. 2012;18(3):439-46.
16. Klaver YLB, Hendriks T, Lomme RMLM, Rutten HJT, Bleichrodt RP, De Hingh IHJT. Intraoperative versus early postoperative intraperitoneal chemotherapy after cytoreduction for colorectal peritoneal carcinomatosis: an experimental study. Ann Surg Oncol. 2012;19(Suppl 3):S475-82.
17. Witkamp A, Bree E De. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev. 2001;27(6):365-74.
18. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to ''pseudomyxoma peritonei.'' Am J Surg Pathol. 1995;19(12):1390-408.
19. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours Pathology and Genetics of the digestive system. IARC Press: Lyon 2000.
20. Verwaal VJ, Van Tinteren H, Van Ruth S, Zoetmulder F. Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2004;91(6): 739-46.
21. Younan R, Kusamura S, Baratti D, Cloutier A-S, Deraco M. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol. 2008;98(4):253-7.
22. Ryan BDP. Cytoreductive surgery and hyperthermic intraperitonal chemotherapy: history repeating itself or a new standard? American Society of Clinical Oncology 2011:127-128.23.24.
23. Elias D, Glehen O, Pocard M, et al. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix. Ann Surg. 2010; 251(5):896-901.
24. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284-92.
25. Glockzin G, Rochon J, Arnold D, et al. A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial. COMBATAC study protocol. BMC Cancer. 2013;13(1):67.